These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 21726666)

  • 21. Enhanced ratio of signals enables digital mutation scanning for rare allele detection.
    Castellanos-Rizaldos E; Paweletz C; Song C; Oxnard GR; Mamon H; Jänne PA; Makrigiorgos GM
    J Mol Diagn; 2015 May; 17(3):284-92. PubMed ID: 25772705
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aflatoxin-induced TP53 R249S mutation in hepatocellular carcinoma in Thailand: association with tumors developing in the absence of liver cirrhosis.
    Villar S; Ortiz-Cuaran S; Abedi-Ardekani B; Gouas D; Nogueira da Costa A; Plymoth A; Khuhaprema T; Kalalak A; Sangrajrang S; Friesen MD; Groopman JD; Hainaut P
    PLoS One; 2012; 7(6):e37707. PubMed ID: 22675488
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Polymorphism of XRCC1 and the frequency of mutation in codon 249 of the p53 gene in hepatocellular carcinoma among Guangxi population, China.
    Long XD; Ma Y; Huang HD; Yao JG; Qu DY; Lu YL
    Mol Carcinog; 2008 Apr; 47(4):295-300. PubMed ID: 17849423
    [TBL] [Abstract][Full Text] [Related]  

  • 24. p53 mutations cluster at codon 249 in hepatitis B virus-positive hepatocellular carcinomas from China.
    Scorsone KA; Zhou YZ; Butel JS; Slagle BL
    Cancer Res; 1992 Mar; 52(6):1635-8. PubMed ID: 1311638
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 249 TP53 mutation has high prevalence and is correlated with larger and poorly differentiated HCC in Brazilian patients.
    Nogueira JA; Ono-Nita SK; Nita ME; de Souza MM; do Carmo EP; Mello ES; Scapulatempo C; Paranaguá-Vezozzo DC; Carrilho FJ; Alves VA
    BMC Cancer; 2009 Jun; 9():204. PubMed ID: 19558663
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The prevalence of the mutation in codon 249 of the P53 gene in patients with hepatocellular carcinoma (HCC) in Turkey.
    Ozdemir FT; Tiftikci A; Sancak S; Eren F; Tahan V; Akın H; Gündüz F; Kedrah AE; Ustündağ Y; Avşar E; Tözün N; Ozdoğan O
    J Gastrointest Cancer; 2010 Sep; 41(3):185-9. PubMed ID: 20306157
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The point mutation of p53 gene exon7 in hepatocellular carcinoma from Anhui Province, a non HCC prevalent area in China.
    Liu H; Wang Y; Zhou Q; Gui SY; Li X
    World J Gastroenterol; 2002 Jun; 8(3):480-2. PubMed ID: 12046074
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Droplet digital PCR detects high rate of TP53 R249S mutants in cell-free DNA of middle African patients with hepatocellular carcinoma.
    Marchio A; Amougou Atsama M; Béré A; Komas NP; Noah Noah D; Atangana PJA; Camengo-Police SM; Njouom R; Bekondi C; Pineau P
    Clin Exp Med; 2018 Aug; 18(3):421-431. PubMed ID: 29749584
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sensitivity of electrospray ionization mass spectrometry detection of codon 249 mutations in the p53 gene compared with RFLP.
    Qian GS; Kuang SY; He X; Groopman JD; Jackson PE
    Cancer Epidemiol Biomarkers Prev; 2002 Oct; 11(10 Pt 1):1126-9. PubMed ID: 12376521
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A pilot study of ultra-deep targeted sequencing of plasma DNA identifies driver mutations in hepatocellular carcinoma.
    Labgaa I; Villacorta-Martin C; D'Avola D; Craig AJ; von Felden J; Martins-Filho SN; Sia D; Stueck A; Ward SC; Fiel MI; Mahajan M; Tabrizian P; Thung SN; Ang C; Friedman SL; Llovet JM; Schwartz M; Villanueva A
    Oncogene; 2018 Jul; 37(27):3740-3752. PubMed ID: 29628508
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Correlation between clinical characteristics and mitochondrial D-loop DNA mutations in hepatocellular carcinoma.
    Tamori A; Nishiguchi S; Nishikawa M; Kubo S; Koh N; Hirohashi K; Shiomi S; Inoue M
    J Gastroenterol; 2004 Nov; 39(11):1063-8. PubMed ID: 15580399
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection of p53 Mutations in Circulating DNA of Transplanted Hepatocellular Carcinoma Patients as a Biomarker of Tumor Recurrence.
    García-Fernández N; Macher HC; Rubio A; Jiménez-Arriscado P; Bernal-Bellido C; Bellido-Díaz ML; Suárez-Artacho G; Guerrero JM; Gómez-Bravo MA; Molinero P
    Adv Exp Med Biol; 2016; 924():25-28. PubMed ID: 27753013
    [TBL] [Abstract][Full Text] [Related]  

  • 33. TP53 mutations and hepatocellular carcinoma: insights into the etiology and pathogenesis of liver cancer.
    Hussain SP; Schwank J; Staib F; Wang XW; Harris CC
    Oncogene; 2007 Apr; 26(15):2166-76. PubMed ID: 17401425
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Allele-specific PCR analysis of p53 codon 249 AGT transversion in liver tissues from patients with viral hepatitis.
    Kirby GM; Batist G; Fotouhi-Ardakani N; Nakazawa H; Yamasaki H; Kew M; Cameron RG; Alaoui-Jamali MA
    Int J Cancer; 1996 Sep; 68(1):21-5. PubMed ID: 8895534
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel method for PIK3CA mutation analysis: locked nucleic acid--PCR sequencing.
    Ang D; O'Gara R; Schilling A; Beadling C; Warrick A; Troxell ML; Corless CL
    J Mol Diagn; 2013 May; 15(3):312-8. PubMed ID: 23541593
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Temperature-tolerant COLD-PCR reduces temperature stringency and enables robust mutation enrichment.
    Castellanos-Rizaldos E; Liu P; Milbury CA; Guha M; Brisci A; Cremonesi L; Ferrari M; Mamon H; Makrigiorgos GM
    Clin Chem; 2012 Jul; 58(7):1130-8. PubMed ID: 22587896
    [TBL] [Abstract][Full Text] [Related]  

  • 37. SIRT1 regulates oncogenesis via a mutant p53-dependent pathway in hepatocellular carcinoma.
    Zhang ZY; Hong D; Nam SH; Kim JM; Paik YH; Joh JW; Kwon CH; Park JB; Choi GS; Jang KY; Park CK; Kim SJ
    J Hepatol; 2015 Jan; 62(1):121-30. PubMed ID: 25131770
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatocellular carcinoma and liver cirrhosis TP53 mutation analysis reflects a moderate dietary exposure to aflatoxins in Espírito Santo State, Brazil.
    de Carvalho FM; de Almeida Pereira T; Gonçalves PL; Jarske RD; Pereira FE; Louro ID
    Mol Biol Rep; 2013 Aug; 40(8):4883-7. PubMed ID: 23649769
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ligation-Mediated Polymerase Chain Reaction Detection of 8-Oxo-7,8-Dihydro-2'-Deoxyguanosine and 5-Hydroxycytosine at the Codon 176 of the p53 Gene of Hepatitis C-Associated Hepatocellular Carcinoma Patients.
    Galli A; Munnia A; Cellai F; Tarocchi M; Ceni E; van Schooten FJ; Godschalk R; Giese RW; Peluso M
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32942546
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The relation between p53 mutations and tumor invasiveness of human hepatocellular carcinoma].
    Qin L; Tang Z; Liu K
    Zhonghua Zhong Liu Za Zhi; 1995 Nov; 17(6):405-8. PubMed ID: 8697987
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.